PTC Therapeutics, Inc. (PTCT)
63.20
+0.64
(+1.03%)
USD |
NASDAQ |
Oct 09, 11:25
PTC Therapeutics Max Drawdown (5Y) : 73.78% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 73.78% |
| August 31, 2026 | 73.78% |
| July 31, 2026 | 73.78% |
| June 30, 2026 | 73.78% |
| May 31, 2026 | 73.78% |
| April 30, 2026 | 73.78% |
| March 31, 2026 | 73.78% |
| February 28, 2026 | 73.78% |
| January 31, 2026 | 73.78% |
| December 31, 2025 | 73.78% |
| November 30, 2025 | 73.78% |
| October 31, 2025 | 73.78% |
| September 30, 2025 | 73.78% |
| August 31, 2025 | 73.78% |
| July 31, 2025 | 73.78% |
| June 30, 2025 | 73.78% |
| May 31, 2025 | 73.78% |
| April 30, 2025 | 73.78% |
| March 31, 2025 | 73.78% |
| February 28, 2025 | 73.78% |
| January 31, 2025 | 73.78% |
| December 31, 2024 | 73.78% |
| November 30, 2024 | 73.78% |
| October 31, 2024 | 73.78% |
| September 30, 2024 | 73.78% |
| Date | Value |
|---|---|
| August 31, 2024 | 73.78% |
| July 31, 2024 | 73.78% |
| June 30, 2024 | 73.78% |
| May 31, 2024 | 73.78% |
| April 30, 2024 | 73.78% |
| March 31, 2024 | 73.78% |
| February 29, 2024 | 73.78% |
| January 31, 2024 | 73.78% |
| December 31, 2023 | 73.78% |
| November 30, 2023 | 73.78% |
| October 31, 2023 | 73.14% |
| September 30, 2023 | 67.48% |
| August 31, 2023 | 63.77% |
| July 31, 2023 | 63.77% |
| June 30, 2023 | 63.77% |
| May 31, 2023 | 63.77% |
| April 30, 2023 | 64.23% |
| March 31, 2023 | 66.85% |
| February 28, 2023 | 66.85% |
| January 31, 2023 | 70.35% |
| December 31, 2022 | 77.48% |
| November 30, 2022 | 79.66% |
| October 31, 2022 | 80.47% |
| September 30, 2022 | 80.47% |
| August 31, 2022 | 80.47% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Biogen, Inc. | 72.66% |
| BioMarin Pharmaceutical, Inc. | 58.73% |
| Arcturus Therapeutics Holdings, Inc. | 95.23% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 3.027 |
| Beta (5Y) | 0.4911 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.86% |
| Historical Sharpe Ratio (5Y) | 0.1448 |
| Historical Sortino (5Y) | 0.2406 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.44% |